Clinical and histologic effect of transrectal intraprostatic injections with botulinum toxin A in patients with lower urinary tract symptoms caused by benign prostatic hyperplasia.
Phase of Trial: Phase II
Latest Information Update: 27 Jun 2016
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Acronyms BOP1
- 25 Apr 2007 New trial record.